Novel N,N-dimethylbarbituric-pyridinium derivatives as potent urease inhibitors: Synthesis, in vitro, and in silico studies

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy et al. · Advanced Drug Delivery Reviews · 1997 · 11K citations

Development Settings, Pharmaceutical Science, Drug Target +8

Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

Daniel F. Veber, Stephen R. Johnson, Hung‐Yuan Cheng et al. · Journal of Medicinal Chemistry · 2002 · 7.8K citations

Medicinal Chemistry, Oral Bioavailability, Pharmaceutical Science +13

Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery

Arup K. Ghose, Torsten Herbertz, Robert L. Hudkins et al. · ACS Chemical Neuroscience · 2011 · 432 citations · Full text

Cns Drug Discovery, Pharmaceutical Research, Drug Target +18

Large-scale virtual screening for the identification of new Helicobacter pylori urease inhibitor scaffolds

Homa Azizian, Farzaneh Nabati, Amirhossein Sharifi et al. · Journal of Molecular Modeling · 2011 · 77 citations

Translational Medicine, Antimicrobial Drug Discovery, Engineering +9

Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease

Emre Menteşe, Hakan Bektaş, Bahar Bilgin Sökmen et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 69 citations · Full text